Collection
The Place of Meropenem-Vaborbactam in the Management of Carbapenem-Resistant Gram-Negative Infections
- Submission status
- Closed
A collection of articles describing the growing issue of antimicrobial resistance among Gram-negative bacteria, ephalosporin-resistant Enterobacterales, as well as the development of Meropenem–Vaborbactam
Articles (5 in this collection)
-
-
Clinical Outcomes of Patient Subgroups in the TANGO II Study
Authors
- Tanaya Bhowmick
- Content type: Commentary
- Open Access
- Published: 09 February 2021
- Pages: 35 - 46
-
Continuous Evolution: Perspective on the Epidemiology of Carbapenemase Resistance Among Enterobacterales and Other Gram-Negative Bacteria
Authors
- Glen T. Hansen
- Content type: Review
- Open Access
- Published: 25 January 2021
- Pages: 75 - 92
-
An Appraisal of the Pharmacokinetic and Pharmacodynamic Properties of Meropenem-Vaborbactam
Authors
- Eric Wenzler
- Patrick J. Scoble
- Content type: Review
- Open Access
- Published: 06 October 2020
- Pages: 769 - 784
-
Microbiology of Meropenem-Vaborbactam: A Novel Carbapenem Beta-Lactamase Inhibitor Combination for Carbapenem-Resistant Enterobacterales Infections
Authors
- Tanaya Bhowmick
- Melvin P. Weinstein
- Content type: Review
- Open Access
- Published: 05 October 2020
- Pages: 757 - 767